Lord, Abbett & Co. LLC Novo Nordisk A S Transaction History

Lord, Abbett & Co. LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Oct 07, 2024	BUY	$102.55 - $135.33 $39.3 Million - $51.9 Million	383,201 New	383,201 $51.9 Million
Q4 2022 Feb 10, 2023	BUY	$102.55 - $135.33 $6.3 Million - $8.32 Million	61,447 Added 19.1%	383,201 $51.9 Million
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $57.3 Million - $70.3 Million	-600,982 Reduced 65.13%	321,754 $32.1 Million
Q2 2022 Aug 12, 2022	BUY	$103.24 - $121.81 $38.8 Million - $45.8 Million	376,178 Added 68.83%	922,736 $103 Million
Q1 2022 May 13, 2022	BUY	$93.1 - $112.54 $50.9 Million - $61.5 Million	546,558 New	546,558 $60.7 Million

1,955

318M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $193B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.